A portable graphical link to your paper (QR code) is provided below. If the code is placed, for example, on a poster, your paper can be accessed through a mobile device's QR code reader.

Right click on the image below to save it to your device.

QR Code for 10.1101/2021.07.23.21261026

Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial